Axikin Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Axikin Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011807
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Axikin Pharmaceuticals Inc (Axikin) is a biopharmaceutical company that develops small molecule therapeutics for respiratory disorders. The company offers pre-clinical and research programs with small molecule therapeutics for applications in asthma, chronic obstructive pulmonary disease, inflammatory dermatoses, inflammatory bowel disease, and rheumatoid arthritis. Its research areas include asthma and COPD that comprise chronic inflammatory disorder of the airways in which patients may experience acute exacerbations and diseases including emphysema and chronic bronchitis reflecting a progressive and irreversible loss of airway function that might result in death. Axikin Pharmaceuticals is headquartered in San Diego, California, the US.

Axikin Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Axikin Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Axikin Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Axikin Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Axikin Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Axikin Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Axikin Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Axikin Pharma Raises US$6 Million In Venture Financing 10
Axikin Raises USD6.5 Million in Venture Financing 11
Axikin Pharma Raises US$2 Million In Venture Financing 12
Axikin Pharmaceuticals Inc – Key Competitors 13
Axikin Pharmaceuticals Inc – Key Employees 14
Axikin Pharmaceuticals Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Axikin Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Axikin Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Axikin Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Axikin Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Axikin Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Axikin Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Axikin Pharma Raises US$6 Million In Venture Financing 10
Axikin Raises USD6.5 Million in Venture Financing 11
Axikin Pharma Raises US$2 Million In Venture Financing 12
Axikin Pharmaceuticals Inc, Key Competitors 13
Axikin Pharmaceuticals Inc, Key Employees 14

★海外企業調査レポート[Axikin Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • QS Energy, Inc. (QSEP):企業の財務及び戦略的SWOT分析
    Summary QS Energy, Inc. (QS Energy), formerly Save The World Air, Inc. is an industrial equipment and components company that develops and commercializes energy technologies. It designs and manufactures production models and tests devices. QS Energy also promotes crude oil pipeline technology, servi …
  • Oil Search Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Oil Search Limited Mergers and …
  • Wavin N.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Wavin N.V. Mergers and Acquisit …
  • Coats Group plc:戦略・SWOT・企業財務分析
    Coats Group plc - Strategy, SWOT and Corporate Finance Report Summary Coats Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Vatech Co., Ltd. (043150):企業財務及び戦略的SWOT分析
    Summary Vatech Co., Ltd. (Vatech) is a medical device company that offers imaging systems. The company manufactures, markets, and distributes products based on digital radiography technology. It provides offers dental X-ray systems and 3D CT solutions. Vatech’s products include 2D and 3D imaging sys …
  • Nextera AS:企業のM&A・提携動向(医療分野)
    Summary Nextera AS (Nextera) is a drug discovery company that concentrates on high-resolution target discovery and lead candidate development in HLA class II associated mechanisms. The company offers various approaches to improve therapeutic intervention of disease classes including autoimmune disea …
  • TRANS GENIC, INC.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TRANS GENIC, INC. Mergers and A …
  • LMI Aerospace, Inc.:企業の戦略・SWOT・財務分析
    SummaryLMI Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • Chocoladefabriken Lindt and Sprungli AG:企業の戦略・SWOT・財務分析
    SummaryChocoladefabriken Lindt and Sprungli AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of …
  • Datawatch Corporation (DWCH):企業概要、財務及び戦略的SWOT分析
    Summary Datawatch Corporation (Datawatch) is a software development company. The company offers products such as datawatch desktop, datawatch server and datawatch report mining server. Its datawatch desktop include visual data discovery, data visualizations, analysis of real-time streams, time serie …
  • Petroceltic International PLC (PCI)(石油・ガス分野):企業M&A動向
    Summary Petroceltic International PLC (Petroceltic) is an upstream energy company. It carries out purchase, discovery, production and development of oil and gas assets. Petroceltic owns producing fields in Egypt and Bulgaria; development assets in Algeria and Italy; and exploration assets in Bulgari …
  • SBM Offshore NV (SBMO)-石油・ガス分野:企業M&A・提携分析
    Summary SBM Offshore N.V. (SBM Offshore) is a floating production solutions provider for offshore oil and gas industry. The company designs supplies, installs and operates Floating Production, Storage and Offloading (FPSO) vessels. The company leases its FPSO vessels to its clients. It also undertak …
  • Alere Toxicology Plc:企業概要及び戦略的SWOT分析
    Alere Toxicology Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Notting Hill Housing Group:企業の戦略・SWOT・財務分析
    SummaryNotting Hill Housing Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Ecologic Transportation, Inc. (formerly USR Technology, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ecologic Transportation, Inc. ( …
  • Biomedical Structures LLC:企業のM&A・提携動向(医療機器分野)
    Summary Biomedical Structures LLC (BMS) is a medical device company that designs, develops and manufactures medical textiles. The company manufacturers devices and structures including knitted, braided, woven, non-woven, custom structures, and materials. It offers consulting services such as design …
  • Luna Innovations Inc (LUNA):企業財務及び戦略的SWOT分析
    Summary Luna Innovations Inc (Luna) is a technology development company that research, develops and commercializes speed optics and fiber optic test products. The company’s products include fiber optic sensing products, fiber optic test and measurement products, high speed optical products, terahert …
  • Erba Diagnostics, Inc. (ERB):企業のM&A・提携動向(医療機器分野)
    Summary Erba Diagnostics, Inc. (Erba Diagnostics), a subsidiary of ERBA Mannheim Group is a medical device company that develops, manufactures and markets diagnostic test kits, reagents, assays and automated systems. The company offers regents that are liquid stable, powders, calibrators and control …
  • Tikcro Technologies, Ltd. (TIKRF):企業の財務及び戦略的SWOT分析
    Summary Tikcro Technologies, Ltd. (Tikcro) is a biopharmaceutical company that discovers, develops, manufactures and markets antibodies to treat various types of cancer. The company undertakes clinical trials for PD1 and CTLA-4 products. Its products are used to treat pancreatic cancer, superficial …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆